Merck & Co., Inc. ($MRK) Possible Buy to $65 Confident Investor Rating: Good

Company name Merck & Co., Inc.
Stock ticker MRK
Live stock price [stckqut]MRK[/stckqut]
P/E compared to competitors Good


Employee productivity Good
Sales growth Fair
EPS growth Good
P/E growth Good
EBIT growth Good


Confident Investor Rating Good
Target stock price (TWCA growth scenario) $67.23
Target stock price (averages with growth) $80.66
Target stock price (averages with no growth) $70.94
Target stock price (manual assumptions) $64.58

The following company description is from Google Finance:
Merck & Co., Inc. (Merck) is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company’s operations are principally managed on a products basis and consists of four segments: the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment: the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. In May 2011, it acquired Inspire Pharmaceuticals, Inc. In September 2011, the Company sold its 50% interest in the Johnson & Johnson-Merck Consumer Pharmaceuticals Company joint venture. In December 2011, the Company established an Asia Research & Development (R&D) headquarters for drug discovery and development located in Beijing, China.


Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.

If you would like to understand how to evaluate companies like I do on this site, please read my book, The Confident Investor.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.